Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Côte d’Ivoire

PLoS Neglected Tropical Diseases

Volumn 11, Issue 10, 2017, Pages

  Ahouty, Bernardin ^a   Koffi, Mathurin ^b   Ilboudo, Hamidou ^c   Simo, Gustave ^d   Matovu, Enock ^e   Mulindwa, Julius ^e   Hertz Fowler, Christiane ^f   Bucheton, Bruno ^g   Sidibé, Issa ^c   Jamonneau, Vincent ^g,h   MacLeod, Annette ⁱ   Noyes, Harry ^f   N’Guetta, Simon Pierre ^a  

^a UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^b Jean Lorougnon GUEDE University   (Côte d’Ivoire)

^c Centre International de Recherche Developpement sur lElevage en zone Subhumide Bobo Dioulasso   (Burkina Faso)

^d University of Dchang   (Cameroon)

^e MAKERERE UNIVERSITY   (Uganda)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^h Institut Pierre Richet Bouake   (Côte d’Ivoire)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; COMPLEMENT FACTOR H; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; PROLYLLEUCYLGLYCINAMIDE; TUMOR NECROSIS FACTOR; APOL1 PROTEIN, HUMAN; APOLIPOPROTEIN; HIGH DENSITY LIPOPROTEIN; IL4 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; ISOMERASE; MIF PROTEIN, HUMAN;

ADULT; AFRICAN TRYPANOSOMIASIS; ARTICLE; CONTROLLED STUDY; COTE D'IVOIRE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION STUDY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; STUDY DESIGN; TRYPANOSOMA BRUCEI GAMBIENSE; ADOLESCENT; AGED; CASE CONTROL STUDY; CHILD; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PARASITOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; TRYPANOSOMIASIS, AFRICAN; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS; CASE-CONTROL STUDIES; CHILD; COTE D'IVOIRE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-4; INTERLEUKIN-6; INTRAMOLECULAR OXIDOREDUCTASES; LIPOPROTEINS, HDL; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 85033407601     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0005992     Document Type: Article

References (48)

1. Simarro PP, Diarra A, Ruiz Postigo JA, Franco JR, Jannin JG, (2011) The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000–2009: the way forward. PLoS Negl Trop Dis5: e1007. doi: 10.1371/journal.pntd.0001007 21364972
2. WHO (2013) Control and surveillance of human African trypanosomiasis. WHO Technical Report Series 984 Geneva.
3. Checchi F, Filipe JA, Barrett MP, Chandramohan D, (2008) The natural progression of Gambiense sleeping sickness: what is the evidence?PLoS Negl Trop Dis2: e303. doi: 10.1371/journal.pntd.0000303 19104656
4. Garcia A, Jamonneau V, Magnus E, Laveissiere C, Lejon V, et al. (2000) Follow-up of Card Agglutination Trypanosomiasis Test (CATT) positive but apparently aparasitaemic individuals in Cote d'Ivoire: evidence for a complex and heterogeneous population. Trop Med Int Health5: 786–793. 11123826
5. Jamonneau V, Ilboudo H, Kabore J, Kaba D, Koffi M, et al. (2012) Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal. PLoS Negl Trop Dis6: e1691. doi: 10.1371/journal.pntd.0001691 22720107
6. Kabore J, Macleod A, Jamonneau V, Ilboudo H, Duffy C, et al. (2011) Population genetic structure of Guinea Trypanosoma brucei gambiense isolates according to host factors. Infect Genet Evol11: 1129–1135. doi: 10.1016/j.meegid.2011.04.011 21515408
7. Koffi M, De Meeus T, Bucheton B, Solano P, Camara M, et al. (2009) Population genetics of Trypanosoma brucei gambiense, the agent of sleeping sickness in Western Africa. Proc Natl Acad Sci U S A106: 209–214. doi: 10.1073/pnas.0811080106 19106297
8. Ilboudo H, Bras-Goncalves R, Camara M, Flori L, Camara O, et al. (2014) Unravelling human trypanotolerance: IL8 is associated with infection control whereas IL10 and TNFalpha are associated with subsequent disease development. PLoS Pathog10: e1004469. doi: 10.1371/journal.ppat.1004469 25375156
9. Bucheton B, MacLeod A, Jamonneau V, (2011) Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections. Parasite Immunol33: 438–447. doi: 10.1111/j.1365-3024.2011.01287.x 21385185
10. Jamonneau V, Ravel S, Garcia A, Koffi M, Truc P, et al. (2004) Characterization of Trypanosoma brucei s.l. infecting asymptomatic sleeping-sickness patients in Cote d'Ivoire: a new genetic group?Ann Trop Med Parasitol98: 329–337. doi: 10.1179/000349804225003406 15228714
11. Courtin D, Argiro L, Jamonneau V, N'Dri L, N'Guessan P, et al. (2006) Interest of tumor necrosis factor-alpha -308 G/A and interleukin-10–592 C/A polymorphisms in human African trypanosomiasis. Infect Genet Evol6: 123–129. doi: 10.1016/j.meegid.2005.03.002 15894515
12. Courtin D, Milet J, Sabbagh A, Massaro JD, Castelli EC, et al. (2013) HLA-G 3' UTR-2 haplotype is associated with Human African trypanosomiasis susceptibility. Infect Genet Evol17: 1–7. doi: 10.1016/j.meegid.2013.03.004 23541412
13. Iraqi F, Clapcott SJ, Kumari P, Haley CS, Kemp SJ, et al. (2000) Fine mapping of trypanosomiasis resistance loci in murine advanced intercross lines. Mamm Genome11: 645–648. 10920233
14. Kemp SJ, Iraqi F, Darvasi A, Soller M, Teale AJ, (1997) Localization of genes controlling resistance to trypanosomiasis in mice. Nat Genet16: 194–196. doi: 10.1038/ng0697-194 9171834
15. Courtin D, Milet J, Jamonneau V, Yeminanga CS, Kumeso VK, et al. (2007) Association between human African trypanosomiasis and the IL6 gene in a Congolese population. Infect Genet Evol7: 60–68. doi: 10.1016/j.meegid.2006.04.001 16720107
16. Stijlemans B, Leng L, Brys L, Sparkes A, Vansintjan L, et al. (2014) MIF contributes to Trypanosoma brucei associated immunopathogenicity development. PLoS Pathog10: e1004414. doi: 10.1371/journal.ppat.1004414 25255103
17. Tiberti N, Hainard A, Lejon V, Robin X, Ngoyi DM, et al. (2010) Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis. Mol Cell Proteomics9: 2783–2795. doi: 10.1074/mcp.M110.001008 20724469
18. Bakhiet M, Jansson L, Buscher P, Holmdahl R, Kristensson K, et al. (1996) Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4. J Immunol157: 3518–3526. 8871651
19. MacLean L, Chisi JE, Odiit M, Gibson WC, Ferris V, et al. (2004) Severity of human african trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile. Infect Immun72: 7040–7044. doi: 10.1128/IAI.72.12.7040-7044.2004 15557627
20. Pays E, Vanhollebeke B, Vanhamme L, Paturiaux-Hanocq F, Nolan DP, et al. (2006) The trypanolytic factor of human serum. Nat Rev Microbiol4: 477–486. doi: 10.1038/nrmicro1428 16710327
21. Ilboudo H, Berthier D, Camara M, Camara O, Kabore J, et al. (2012) APOL1 expression is induced by Trypanosoma brucei gambiense infection but is not associated with differential susceptibility to sleeping sickness. Infect Genet Evol12: 1519–1523. doi: 10.1016/j.meegid.2012.05.010 22691369
22. Yamada Y, Metoki N, Yoshida H, Satoh K, Ichihara S, et al. (2006) Genetic risk for ischemic and hemorrhagic stroke. Arterioscler Thromb Vasc Biol26: 1920–1925. doi: 10.1161/01.ATV.0000229694.97827.38 16741147
23. Raj DS, (2009) Role of interleukin-6 in the anemia of chronic disease. Semin Arthritis Rheum38: 382–388. doi: 10.1016/j.semarthrit.2008.01.006 18336871
24. Perera MK, Herath NP, Pathirana SL, Phone-Kyaw M, Alles HK, et al. (2013) Association of high plasma TNF-alpha levels and TNF-alpha/IL-10 ratios with TNF2 allele in severe P. falciparum malaria patients in Sri Lanka. Pathog Glob Health107: 21–29. doi: 10.1179/2047773212Y.0000000069 23432860
25. Gichohi-Wainaina WN, Melse-Boonstra A, Swinkels DW, Zimmermann MB, Feskens EJ, et al. (2015) Common Variants and Haplotypes in the TF, TNF-alpha, and TMPRSS6 Genes Are Associated with Iron Status in a Female Black South African Population. J Nutr145: 945–953. doi: 10.3945/jn.114.209148 25809685
26. Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, et al. (1999) A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet22: 145–150. doi: 10.1038/9649 10369255
27. Tu IP, Whittemore AS, (1999) Power of association and linkage tests when the disease alleles are unobserved. Am J Hum Genet64: 641–649. doi: 10.1086/302253 9973303
28. Magez S, Caljon G, (2011) Mouse models for pathogenic African trypanosomes: unravelling the immunology of host-parasite-vector interactions. Parasite Immunol33: 423–429. doi: 10.1111/j.1365-3024.2011.01293.x 21480934
29. Daulouede S, Bouteille B, Moynet D, De Baetselier P, Courtois P, et al. (2001) Human macrophage tumor necrosis factor (TNF)-alpha production induced by Trypanosoma brucei gambiense and the role of TNF-alpha in parasite control. J Infect Dis183: 988–991. doi: 10.1086/319257 11237819
30. Magez S, Radwanska M, Beschin A, Sekikawa K, De Baetselier P, (1999) Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect Immun67: 3128–3132. 10338530
31. Cooper A, Ilboudo H, Alibu VP, Ravel S, Enyaru J, et al. (2017) APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis. Elife6.
32. Kabore WJ, Ilboudo H, Noyes H, Camara O, Kabore J, et al. (2017) Candidate gene study between human African trypanosomiasis clinical phenotypes in Guinea. PLoS Negl Trop Dis in press.
33. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science329: 841–845. doi: 10.1126/science.1193032 20647424
34. Barton A, Lamb R, Symmons D, Silman A, Thomson W, et al. (2003) Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun4: 487–491. doi: 10.1038/sj.gene.6364014 14551601
35. Rosado Jde D, Rodriguez-Sosa M, (2011) Macrophage migration inhibitory factor (MIF): a key player in protozoan infections. Int J Biol Sci7: 1239–1256. 22110378
36. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, et al. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med13: 587–596. doi: 10.1038/nm1567 17435771
37. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, et al. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature377: 68–71. doi: 10.1038/377068a0 7659164
38. Stijlemans B, Beschin A, Magez S, Van Ginderachter JA, De Baetselier P, (2015) Iron Homeostasis and Trypanosoma brucei Associated Immunopathogenicity Development: A Battle/Quest for Iron. Biomed Res Int2015: 819389. doi: 10.1155/2015/819389 26090446
39. Lajoie J, Hargrove J, Zijenah LS, Humphrey JH, Ward BJ, et al. (2006) Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. J Infect Dis193: 298–301. doi: 10.1086/498877 16362895
40. Ferguson R, Ramanakumar AV, Richardson H, Tellier PP, Coutlee F, et al. (2011) Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. Hum Immunol72: 337–341. doi: 10.1016/j.humimm.2011.01.010 21256910
41. Lafon M, Prehaud C, Megret F, Lafage M, Mouillot G, et al. (2005) Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol79: 15226–15237. doi: 10.1128/JVI.79.24.15226-15237.2005 16306594
42. Zhao M, Zhang R, Xu X, Liu Y, Zhang H, et al. (2013) IL-10 reduces levels of apoptosis in Toxoplasma gondii-infected trophoblasts. PLoS One8: e56455. doi: 10.1371/journal.pone.0056455 23418570
43. Jamonneau V, Bucheton B, Kabore J, Ilboudo H, Camara O, et al. (2010) Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa. PLoS Negl Trop Dis4: e917. doi: 10.1371/journal.pntd.0000917 21200417
44. Ilboudo H, Noyes H, Mulindwa J, Kimuda MP, Koffi M, et al. (2017) Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasis. PLoS Negl Trop Dis11: e0005438. doi: 10.1371/journal.pntd.0005438 28570558
45. Zhao JH, (2007) Gap: genetic analysis package. J Stat Soft23: 1–18.
46. Gray IC, Campbell DA, Spurr NK, (2000) Single nucleotide polymorphisms as tools in human genetics. Hum Mol Genet9: 2403–2408. 11005795
47. Weir BS, Cockerham CC, (1984) Estimating F-Statistics for the Analysis of Population Structure. Evol38: 1358–1370.
48. Semagn k, Babu R, Hearn S, Olsen MS, (2013) Single nucleotide polymorphism genotyping using Kompetitive Allele Specific PCR (KASP): Overview of the technology and its application in crop improvement. Mol Breed33: 1–14.